Last: | $332.59 |
---|---|
Change Percent: | -0.42% |
Open: | $334.6 |
Close: | $333.98 |
High: | $334.77 |
Low: | $330.46 |
Volume: | 138,122 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$332.59 | $334.6 | $333.98 | $334.77 | $330.46 | 138,122 | 05-17-2024 |
$333.98 | $332 | $333.98 | $335 | $331.35 | 1,108,008 | 05-16-2024 |
$331.99 | $325.91 | $331.99 | $332.22 | $324.3 | 1,757,419 | 05-15-2024 |
$324.3 | $324.09 | $324.3 | $326.0225 | $322.5 | 1,712,601 | 05-14-2024 |
$324.56 | $331.32 | $324.56 | $331.32 | $323.51 | 1,609,587 | 05-13-2024 |
$330.58 | $331.8 | $330.58 | $332.815 | $330.15 | 1,307,926 | 05-10-2024 |
$330.86 | $330.41 | $330.86 | $332.7453 | $329.29 | 980,439 | 05-09-2024 |
$329.28 | $331.94 | $329.28 | $335.395 | $327.6 | 1,169,848 | 05-08-2024 |
$332.14 | $327.93 | $332.14 | $332.39 | $326.63 | 1,331,236 | 05-07-2024 |
$325.5 | $330.3 | $325.5 | $331 | $324.59 | 1,722,244 | 05-06-2024 |
$328.45 | $328.65 | $328.45 | $331.7625 | $326.701 | 1,589,424 | 05-03-2024 |
$326.63 | $331.68 | $326.63 | $331.68 | $322.51 | 1,846,993 | 05-02-2024 |
$328.12 | $333.58 | $328.12 | $335.725 | $320.715 | 2,766,931 | 05-01-2024 |
$336.5 | $337.65 | $336.5 | $340.41 | $336.32 | 2,439,750 | 04-30-2024 |
$338.87 | $334.67 | $338.87 | $340.42 | $334.67 | 1,507,424 | 04-29-2024 |
$335.61 | $335.19 | $335.61 | $338.51 | $334.44 | 1,063,790 | 04-26-2024 |
$337.15 | $335.84 | $337.15 | $337.87 | $333.33 | 1,525,802 | 04-25-2024 |
$336.85 | $335.28 | $336.85 | $342.595 | $334.2 | 1,478,179 | 04-24-2024 |
$334.91 | $328.55 | $334.91 | $335.12 | $327 | 1,430,549 | 04-23-2024 |
$327.68 | $327.71 | $327.68 | $329.43 | $323.75 | 1,688,622 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Infinity with Adaptis and Everlast Total Ankle System, featuring Prophecy Surgical Planning, is designed to deliver efficient and accurate implementation Stryker (NYSE:SYK), a global leader in medical technologies, announced the successful completion of the first European surgeries using ...
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.91% on an annualized basis producing an average annual return of 9.83%. ...
2024-05-02 09:30:06 ET Barclays analyst issues OVERWEIGHT recommendation for SYK on May 2, 2024 07:48AM ET. The previous analyst recommendation was Overweight. SYK was trading at $328.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...